NewsBur
No Result
View All Result
Tuesday, January 19, 2021
  • Home
  • Morning News
  • Market News
  • Analyst Actions
  • Trending Stocks
Subscribe
Newsbur
  • Home
  • Morning News
  • Market News
  • Analyst Actions
  • Trending Stocks
No Result
View All Result
Newsbur
No Result
View All Result
Home Market News

Sutro Biopharma Inc. [STRO]’s Market Cap is $422.05 million and Here is Where it Goes Next

by Shawn Johnson
September 15, 2020
in Market News
0
0
SHARES
17
VIEWS
Share on FacebookShare on Twitter

Sutro Biopharma Inc. [NASDAQ:STRO] shares are showing some interesting activity. The company’s daily low is at $10.55 as the high is reaching $11.50.

If readers are not familiar, Sutro Biopharma Inc. is in the Healthcare sector under the Biotechnology industry. This week, we are watching the stock hit price per sales of 10.50 with an earning per share of -1.11.

As a reference point, the S&P 500 is trading 1.26% over the last 52 weeks, while STRO stock is trading -0.91%.

The Price is right

Holding a Market Cap of $422.05 million, Sutro Biopharma Inc. has seen a trading range over the last year of $6.00-$13.91.

For the last five days, STRO is down from its last closing price. The average shares trading hands each day is 302.37K.

Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for STRO. When we apply the Elder Force Index to Sutro Biopharma Inc., we are seeing an Elder Force Indicator number of 880911.91.

Recent Performance

In the last quarter, STRO made a profit of 25.89 million. Sutro Biopharma Inc. also saw quarter revenue growth year over year of 11.24%.

Technical Analysis

Looking at popular technical indicators, the company’s 5-day moving average is 11.60 compared to the 50-day moving average of 2.10%. So, we are clearly seeing an upward trajectory here.

The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. STRO currently holds a 9-day RSI of 51.80%, while 100-day RSI stands at 51.54%.

Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. STRO’s 9-day MACD is -0.96 and the company’s 100-day MACD stands at 1.40.

Inside Moves

Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.

The major holders for this stock are 21.16% by insiders and 69.52% by institutions. Regarding institutional holdings, BVF Inc. owns 6.60%, while the second top holder, Eventide Asset Management LLC, currently owns 5.54%.

Over the last six months, insiders have sold 975 with the most recent transaction from Hallam Trevor, Chief Scientific Officer, with a sell at price 9.04 per share.

Conclusion

Overall, the recommended rating for STRO is Strong Buy. Currently, the company has 9 analysts watching the stock, and the average quarterly earnings estimate is -0.55. Quarterly revenue estimates are averaging 8.54M with the high estimate reaching 12M and the low at 5M.

Tags: NASDAQ:STROSTROSTRO stockSutro Biopharma Inc.

Recommended Stories

American International Group Inc. [AIG] is One of the Best Plays in Financial and This Proves It

September 15, 2020

Heat Biologics Inc. [HTBX] is One of the Best Plays in Healthcare and This Proves It

August 31, 2020

The Price of EyePoint Pharmaceuticals Inc. [EYPT] Just Hit $0.52

September 1, 2020

Popular Stories

  • Sorrento Therapeutics Inc. [SRNE] is One of the Best Plays in Healthcare and This Proves It

    0 shares
    Share 0 Tweet 0
  • Heat Biologics Inc. [HTBX] is One of the Best Plays in Healthcare and This Proves It

    0 shares
    Share 0 Tweet 0
  • Heat Biologics Inc. [HTBX] Is Skyrocketing 13.15% on Pure Fundamentals

    0 shares
    Share 0 Tweet 0
  • BlackBerry Limited [BB] is a Top Ten Buy with Quarterly Revenues of 999.00M

    0 shares
    Share 0 Tweet 0
  • Impressive Profit Margins of -5.80% Raise Bull Flags for General Electric Company [GE]

    0 shares
    Share 0 Tweet 0

NewsBur.com

Newsbur.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.

Recent Posts

  • After-Hours Trading Alert: Amgen Inc. [AMGN] is Up 0.85% After the Bell
  • Has Dynatrace Inc. [DT] Completely Outpaced Other Companies in the Technology This Year?
  • Why Applied Materials Inc. [AMAT]’s 1.55% Drop is No Cause for Alarm

Categories

  • Analyst Actions
  • Market News
  • Morning News
  • Trending Stocks
  • Uncategorized

© 2020 Copyright © All Rights Reserved.

No Result
View All Result
  • Home
  • Market News
  • Morning News
  • Analyst Actions
  • Trending Stocks

© 2020 Copyright © All Rights Reserved.